Case Summary:

The following factor counted immensely in the National Interest Waiver (NIW) case approval of an Iranian professor in biomedical science:

• As an expert in biomedical science, his proposed endeavor is to continue his development of sustainable state-of-the-art approaches for identifying host and pathogen interactions in order to improve human and animal health.
• His research advancing his proposed endeavor is of great importance because it is driving advances in the surveillance, monitoring, and control of salmonella disease.
• He has also developed powerful and effective typing techniques that allow for the more efficient surveillance and monitoring of salmonella infections. Not only this but he has developed a novel molecular method for detecting and characterizing the bovine leukemia virus in infected cows.
• His proposed research also has broad implications for the United States where his research is key to improving the health and productivity of agricultural animals, especially since the United States is the world’s largest producer of both beef and poultry, and sales of livestock and poultry account for more than half of agricultural cash receipts, exceeding $160 billion on an annual basis.
• He has also completed at least 24 reviews to date and his research has resulted in 87 peer-reviewed journal articles (20 of them first-authored).
• These publications have been cited a massive total of 1,437 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical science.
• Additionally, he has pursued research directly related to his proposed endeavor of developing sustainable state-of-the-art approaches for identifying host and pathogen interactions for approximately 23 years.
• His work experience has been rewarded by recognition from researchers around the world. Four of these experts also wrote letters supporting his work here in the U.S. One of them said:

“[The client’s] cutting-edge approaches produce new knowledge on DNA vaccines and IgY. DNA vaccines have advantages over traditional vaccines, including the ability to be transported at room temperature, diminished replication interference, and the ability of a single vaccination to work against multiple pathogens. [Client’s] work has already resulted in novel oral DNA vaccine designs and pharmaceutical approaches that more effectively protect against influenza. As such, [the client’s] research is highly valuable on a global scale.”

As such, the value of his work becomes apparent and this is what won him the approval in just 11 days of application. Thanks also to the premium processing upgrade for his case which expedited his journey to success.